The implementation of the Digital Healthcare Act (Digitale-Versorgung-Gesetz, DVG) on December 19, 2019, represents a seminal moment in the history of European health technology. By establishing the world’s first formal reimbursement pathway for digital health applications (Digitale Gesundheitsanwendungen, DiGA), Germany effectively transformed software into a regulated medical intervention on par with traditional pharmaceuticals. Seven years on, the ecosystem has moved thro

The 2026 NHS is not a market for "vendors" but for "transformation partners". Success will require an enterprise-wide realignment, from R&D to sales, to the new "digital-by-default," "value-over-volume," and "net-zero" reality of the NHS. Companies must move away from transactional selling and toward a model of shared risk and long-term partnership, demonstrating how their technology helps the NHS achieve its 2% annual productivity ambition while dramatically reducing waiting

The recent initial public offering (IPO) of HeartFlow represents a significant milestone in the convergence of artificial intelligence (AI) and medical technology. The company, which is focused on diagnosing and managing coronary artery disease (CAD), successfully navigated a challenging market to complete a landmark public debut on the Nasdaq Global Select Market under the ticker symbol HTFL. The offering was met with robust investor demand, leading to a significant increase